Current status of haemophilia gene therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current status of haemophilia gene therapy

Published:2014-04-25 Issue: Volume:20 Page:43-49
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

High K. H.¹,Nathwani A.²,Spencer T.³,Lillicrap D.⁴

Affiliation:

1. Center for Cellular and Molecular Therapeutics; The Children's Hospital of Philadelphia; Philadelphia PA USA

2. Katharine Dormandy Haemophilia Centre and Thrombosis Unit; Royal Free Hospital; London UK

3. Department of Pediatrics; Emory University School of Medicine; Atlanta GA USA

4. Richardson Laboratory; Department of Pathology and Molecular Medicine; Queen's University; Kingston ON Canada

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12411/fullpdf

Reference71 articles.

1. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B;Nathwani;N Engl J Med,2011

2. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses;Calcedo;J Infect Dis,2009

3. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy;Jiang;Blood,2006

4. Immune responses to AAV vectors: overcoming barriers to successful gene therapy;Mingozzi;Blood,2013

5. Overcoming preexisting humoral immunity to AAV using capsid decoys;Mingozzi;Sci Transl Med,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular camouflage by a context-specific hydrogel as the key to unlock the potential of viral vector gene therapy;Chemical Engineering Journal;2023-12

2. Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A;Molecular Medicine;2023-06-12

3. Improved Intrvenous Lentiviral Gene Therapy Based on Endothelial-specific Factor VIII for Hemophilia A;2023-03-13

4. Gene therapy – are we ready now?;Haemophilia;2022-05

5. Current Therapies in Hemophilia: From Plasma-Derived Factor Modalities to CRISPR/Cas Alternatives;The Tohoku Journal of Experimental Medicine;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3